Vaccines: United States
Description
This report forecasts to 2029 US vaccine and other product shipments nominal US dollars at the manufacturer level. To illustrate historical trends, total shipments are provided in annual series from 2019 to 2024.
Vaccine and other product shipments include the distribution of vaccines, toxoids, blood fractions, and culture media of plant or animal origin (excluding diagnostics), as defined by NAICS 325414. These products are manufactured for immunization or therapeutic use and shipped to healthcare providers, distributors, and public health agencies.
Key macroeconomic indicators are also provided with quantified trends. Other various topics, including profiles of pertinent leading companies, are covered in this report. A full outline of report items by page is available in the Table of Contents.
Related NAICS Code:
- 325414 Biological Product (except Diagnostic) Manufacturing
Table of Contents
- HIGHLIGHTS
- MARKET ENVIRONMENT
- Historical Trends
- Key Economic Indicators
- Environmental & Regulatory Factors
- Technological Advancements
- SHIPMENT TRENDS & FORECASTS
- Key Influencing Factors
- INDUSTRY STRUCTURE
- Industry Characteristics
- Market Leaders
- ABOUT THIS REPORT
- Scope
- Sources
- Industry Codes
- Freedonia Methodology
- Resources
Search Inside Report
Pricing
Currency Rates

